secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001558370-23-016259
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sandip Kapadia named CFO and CAO; 150k RSUs granted to Kapadia and Dierks
-------------------------------------------------------------------------

- Sandip Kapadia appointed CFO and Chief Administrative Officer effective Sep 30, 2023.
- Kapadia receives 150,000 RSUs vesting 40% year 1, 30% year 2, 30% year 3.
- Chief Commercial Officer Jeffrey Dierks also receives 150,000 RSUs on same vesting schedule.
- Unvested RSUs accelerate on termination without cause (subject to release).
- Both awards are retention grants under the 2020 Incentive Award Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023016259/0001558370-23-016259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023016259/hrmy-20230930x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-016259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer